Versant Venture Capital IV, L.P., 10% Owner at CRISPR Therapeutics AG (CRSP), sold 695,496 shares at $50.66 ($10.1M) on 2018-04-23, disclosed to the SEC on 2018-04-24.
Open-market sale of $10.1M CRSP by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 497,053 | $0 | 0.0% |
| 2 | $50.66 | 6,821 | $346K | 3.4% |
| 3 | $50.66 | 89,628 | $4.5M | 45.2% |
| 4 | $50.66 | 89,628 | $4.5M | 45.2% |
| 5 | $50.66 | 6,821 | $346K | 3.4% |
| 6 | $51.00 | 2,915 |
| $149K |
| 1.5% |
| 7 | $51.00 | 2,630 | $134K | 1.3% |
| Total | $14.46 avg | 695,496 | $10.1M | 100% |
| Filing → |